Case #46 – Clinical Applications of VEPs

Clinical Applications of VEPs – Page 41 of 41

References 1. Sherman, J., S. Bass, K. Noble, S. Nath, and V. Sutija. "Visual Evoked Potential (VEP) Delays in Central Serous Choroidopathy." Investigative Ophthalmogy & Visual Science 27.2 (1986): 214-21. 2. Barboni, P., G. Savini, M. L. Valentino, C. La Morgia, C. Bellusci, A. M. De Negri, F. Sadun, A. Carta, M. Carbonelli, A.

Clinical Applications of VEPs – Page 41 of 412023-01-31T21:28:39+00:00

Clinical Applications of VEPs – Page 39 of 41

Jerome Sherman, OD, FAAO Jerome Sherman, O.D., is perhaps optometry's most prolific writer, publishing over 650 clinical articles, research manuscripts, book chapters and two CDs. He is senior author of three books that were published in 2007, and has delivered over three thousand lectures both nationally and internationally. He has served as a

Clinical Applications of VEPs – Page 39 of 412023-01-31T21:28:39+00:00

Clinical Applications of VEPs – Page 37 of 41

Comments and Conclusions • VEPs provide objective assessment of macula, optic nerve and visual pathway function. • VEPs generally correlate well with objective tests of structure such as SD OCT. • Pattern and flash VEPs can be used to assess the prognosis in "amblyopes" and identify those who have an organic disorder causing the

Clinical Applications of VEPs – Page 37 of 412023-01-31T21:28:40+00:00

Clinical Applications of VEPs – Page 36 of 41

Case 5: Comparing Objective Structure (GCC) & Objective Function (VEP) Objective structure (GCC) and objective function (VEPs) are both abnormal in the RE and confirm an optic neuropathy but do not identify a specific etiology. The VEP also appears delayed in the LE but the GCC appears

Clinical Applications of VEPs – Page 36 of 412023-01-31T21:28:40+00:00

Clinical Applications of VEPs – Page 35 of 41

Case 5: Diopsys™ Nova-DN OU Visually evoked potentials (VEPs) were obtained with the new Diopsys system, the NOVA (Neuro Optic Vision Assessment). The specific program used was the DN (Diseases of the Optic Nerve) and each testing condition takes only 15 sec or so. Above are VEPs to low and high contrast levels

Clinical Applications of VEPs – Page 35 of 412023-01-31T21:28:41+00:00

Clinical Applications of VEPs – Page 34 of 41

Case 5: iVue GCC Thickness Patient vs. Normal OU The normal GCC appears as a green donut and in a normal patient, the thickness in the RE is very similar to the thickness in the LE. Similarly, the thickness inferiorly is very similar to the thickness superiorly in normal patients. In our patient,

Clinical Applications of VEPs – Page 34 of 412023-01-31T21:28:41+00:00

Clinical Applications of VEPs – Page 33 of 41

Case 5: Topcon 3D OCT Fundus Photo OU Case 5: A 60-year-old WM was reevaluated at the request of his optometrist. Best corrected VA has always been 20/20 in the right and left eye. Decades earlier, the optometrist noticed that the patient's right optic disc appeared to be somewhat more pale than his

Clinical Applications of VEPs – Page 33 of 412023-01-31T21:28:41+00:00

Clinical Applications of VEPs – Page 32 of 41

Case 4: Optovue iWellness Exam Using the iWellness Exam protocol, the GCC appears normal. A review of the 26 retinal sections failed to reveal any abnormality. DIAGNOSIS: The normal VEP suggests that the visual pathway up until Brodmann's Area 17 (or Visual Cortex 1) is intact. Since our patient has some form of

Clinical Applications of VEPs – Page 32 of 412023-01-31T21:28:41+00:00